Bipolar Ii Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Ii Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-22FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for quetiapine fumarate from Accord Healthcare Inc., updating the product's labeling and/or indicati…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Decoding Emotional Dynamics in Bipolar Disorder [NA]
A registered clinical trial evaluating emotional dynamics in individuals with Bipolar I or II disorder compared with healthy controls; curre…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder [Phase 2]
This is a Phase 2 clinical trial evaluating adverse events and changes in disease activity of oral Icalcaprant in adults with bipolar I or I…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder [Phase 1]
A Phase 1 clinical trial evaluating BXCL501 for efficacy and safety in agitation associated with pediatric schizophrenia and related disorde…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the adverse events of oral ABBV-932 in adults with depressive episodes assoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder [Phase 2]
Phase 2 clinical trial assessing measures of acute psychomotor agitation in people with schizophrenia and bipolar disorder has completed. Th…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE) [Phase 3]
Open-label Phase 3 trial evaluating azetukalner for bipolar depression in bipolar I or II disorder. Enrollment is ongoing by invitation.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) [Phase 3]
A Phase 3 randomized trial is evaluating Azetukalner versus placebo for depressive episodes in bipolar disorder (bipolar I or II); the study…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder. [Phase 2]
This Phase 2 trial evaluated NMRA-335140 for depressive symptoms in Bipolar II disorder. The study status is completed.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression [NA]
An update on a clinical trial evaluating low-field magnetic stimulation imaging biomarkers in geriatric bipolar disorder. The study is curre…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Lithium Versus Lamotrigine in Bipolar Disorder, Type II [Phase 4]
A Phase 4 clinical trial is comparing lithium and lamotrigine for Bipolar II Disorder and is currently recruiting. The sponsor listed is Uni…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating an individualized pharmacological approach to obesity in patients with bipolar disorder (bipolar I and II)…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Ketamine for Treatment-Resistant Bipolar Disorder [Phase 2]
A Phase 2 clinical trial evaluating ketamine for treatment-resistant bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression [Phase 2]
A Phase 2 completed trial update evaluating maintenance ketamine infusions for treatment-resistant bipolar depression.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy, safety, and tolerability of lacosamide for major depressive episodes in Bipolar I and II d…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression [NA]
A clinical trial evaluating aerobic physical activity as an add-on treatment for bipolar depression. The study is currently suspended.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Children's Bipolar Network Treatment Trial I
A pediatric bipolar disorder trial sponsored by UCLA is currently recruiting to evaluate treatments for Bipolar Disorder and related conditi…
-
CLINICAL_TRIALS withdrawal · 2026-01-21Clinical Trial Update: Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT [EARLY_Phase 1]
An EARLY Phase 1 clinical trial investigating long-term potentiation disruption underlying cognitive impairment in electroconvulsive therapy…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder [Phase 2]
Phase 2 trial update for ABBV-932 in adults with Bipolar I or Bipolar II disorder, assessing adverse events and changes in disease activity;…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) [Phase 3]
Phase 3 trial evaluating dexmedetomidine for agitation associated with schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
The UnMASCK study aims to unobtrusively monitor affective symptoms and cognition using keyboard dynamics, and the trial is currently active …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder [Phase 3]
A Phase 3 clinical trial is evaluating psilocybin-assisted therapy for treatment-resistant bipolar II depression, with recruitment not yet s…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression [NA]
This clinical trial update notes a study evaluating closed-loop deep brain stimulation for treatment-resistant bipolar depression, with recr…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: ALTO-100 in Bipolar Disorder With Depression (BD-D) [Phase 2]
ALTO-100 is in Phase 2 and currently recruiting for bipolar disorder with a major depressive episode (BD-D).
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Exercise and Olanzapine-samidorphan [Phase 4]
A Phase 4 clinical trial is evaluating exercise in combination with olanzapine-samidorphan for schizophrenia and related disorders, includin…